PROTECTION AGAINST THE NEUROTOXICITY OF OXALIPLATIN THROUGH THE ADMINISTRATION OF CALCIUM AND MAGNESIUM

Details for Australian Patent Application No. 2003216720 (hide)

Owner CENTRE REGIONAL DE LUTTE CONTRE LE CANCER D'ANGERS

Inventors BOISDRON-CELLE, Michele; MOREL, Alain; GAMELIN, Laurence; GAMELIN, Erick

Pub. Number AU-A-2003216720

PCT Number PCT/FR03/00098

PCT Pub. Number WO2003/059361

Priority 02/00390 14.01.02 FR

Filing date 14 January 2003

Wipo publication date 30 July 2003

International Classifications

A61K 033/06 Medicinal preparations containing inorganic active ingredients - Aluminium, calcium or magnesium

A61K 031/7004 - Monosaccharides having only carbon, hydrogen and oxygen atoms

A61P 035/00 Antineoplastic agents

A61K 033/10 Medicinal preparations containing inorganic active ingredients

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 02/00390 14.01.02 FR

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2003216720

30 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003216721-IMPLANTABLE PROSTHESIS FOR CORRECTING EFFORT-RELATED URINARY INCONTINENCE IN WOMEN

2003216719-METHOD AND INSTALLATION FOR THE DENSIFICATION OF SUBSTRATES BY MEANS OF CHEMICAL VAPOUR INFILTRATION